| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2026―Mar―25 |
The Economic Value of Non-pharmaceutical Interventions for Influenza and COVID-19: A Systematic Review |
Hui Yee Yeo, Trinh Manh Hung, Nhung Nghiem, Steffen Albrecht, Nikki Turner, Peter McIntyre |
| 2 |
[GO] |
2025―Jan―20 |
Productivity Losses due to Health Problems Arising from COVID-19 Pandemic: A Systematic Review of Population-Level Studies Worldwide |
Paweł Niewiadomski, Marta Ortega-Ortega, Błażej Łyszczarz |
| 3 |
[GO] |
2024―Apr―19 |
Comparison of the Measurement Properties of EQ-5D-5L and SF-6Dv2 in COVID-19 Patients in China |
Ningxin Ding, Huixuan Zhou, Chen Chen, Hui Chen, Yunfeng Shi |
| 4 |
[GO] |
2024―Apr―10 |
Economic Evaluation of COVID-19 Immunization Strategies: A Systematic Review and Narrative Synthesis |
Enxue Chang, Haofei Li, Wanji Zheng, Lan Zhou, Yanni Jia, Wen Gu, Yiyin Cao, Xiaoying Zhu, Juan Xu, Bo Liu, Mao You, Kejun Liu, Mingsi Wang, Weidong Huang |
| 5 |
[GO] |
2023―Nov―01 |
Cost-Effectiveness of the Second COVID-19 Booster Vaccination in the USA |
Rui Li, Pengyi Lu, Christopher K. Fairley, José A. Pagán, Wenyi Hu, Qianqian Yang, Guihua Zhuang, Mingwang Shen, Yan Li, Lei Zhang |
| 6 |
[GO] |
2023―May―27 |
Symptomatic SARS-CoV-2 Episodes and Health-Related Quality of Life |
Caterina Alacevich, Inna Thalmann, Catia Nicodemo, Simon de Lusignan, Stavros Petrou |
| 7 |
[GO] |
2023―May―08 |
Public Preferences for Introducing a COVID-19 Certificate: A Discrete Choice Experiment in the Netherlands |
J. Veldwijk, J. van Exel, E. W. de Bekker-Grob, N. Mouter |
| 8 |
[GO] |
2023―Mar―16 |
Economic Evaluation of Evusheld for Preexposure Prevention of COVID-19 in High-Risk Populations: Early Evidence from Thailand |
Waranya Rattanavipapong, Chittawan Poonsiri, Wanrudee Isaranuwatchai, Sopon Iamsirithaworn, Jutarat Apakupakul, Chaninan Sonthichai, Rungrueng Kitphati, Yot Teerawattananon |
| 9 |
[GO] |
2022―Sep―14 |
Determinants of COVID-19 Vaccine Rollouts and Their Effects on Health Outcomes |
Pragyan Deb, Davide Furceri, Daniel Jimenez, Siddharth Kothari, Jonathan D. Ostry, Nour Tawk |
| 10 |
[GO] |
2022―Aug―02 |
An Economic Evaluation of Government-Funded COVID-19 Testing in Australia |
Jonathan Karnon, Hossein Haji Ali Afzali, Billie Bonevski |
| 11 |
[GO] |
2022―Jan―10 |
Scope Issue in Contingent Valuation Studies of the COVID-19 Vaccine: The Case of China |
Jianhong Xiao, Yihui Wu, Min Wang, Zegang Ma |
| 12 |
[GO] |
2021―Dec―10 |
The Effects of School Closures on COVID-19: A Cross-Country Panel Analysis |
Vincenzo Alfano |
| 13 |
[GO] |
2021―Nov―29 |
Is There Broad-Based Support in High-Income Countries for COVID-19 Vaccine Donation? Evidence from Seven Countries |
Laurence S. J. Roope, Adrian Barnett, Paolo Candio, Mara Violato, Raymond Duch, Philip M. Clarke |
| 14 |
[GO] |
2021―Nov―01 |
Financial Incentives in the Path to Recovery from the COVID-19 Pandemic |
Afschin Gandjour |
| 15 |
[GO] |
2021―Oct―05 |
COVID-19 Vaccine Demand and Financial Incentives |
Carlos E. Carpio, Ioana A. Coman, Oscar Sarasty, Manuel García |
| 16 |
[GO] |
2021―Jul―27 |
How Much Money Should be Paid for a Patient to Isolate During the COVID-19 Outbreak? A Discrete Choice Experiment in Iran |
Enayatollah Homaie Rad, Mohammad Hajizadeh, Vahid Yazdi-Feyzabadi, Sajad Delavari, Zahra Mohtasham-Amiri |
| 17 |
[GO] |
2021―Jul―08 |
Avoiding Trouble Ahead: Lessons Learned and Suggestions for Economic Evaluations of COVID-19 Vaccines |
Chris Painter, Wanrudee Isaranuwatchai, Juthamas Prawjaeng, Hwee Lin Wee, Brandon Wen Bing Chua, Vinh Anh Huynh, Jing Lou, Fang Ting Goh, Nantasit Luangasanatip, Wirichada Pan-Ngum, Wang Yi, Hannah Clapham, Yot Teerawattananon |
| 18 |
[GO] |
2021―Jun―25 |
Using Constrained Optimization for the Allocation of COVID-19 Vaccines in the Philippines |
Christian Alvin H. Buhat, Destiny S. M. Lutero, Yancee H. Olave, Kemuel M. Quindala, Mary Grace P. Recreo, Dylan Antonio S. J. Talabis, Monica C. Torres, Jerrold M. Tubay, Jomar F. Rabajante |
| 19 |
[GO] |
2021―May―11 |
Comment on: “Willingness to Pay for a COVID-19 Vaccine” |
Philipp Sprengholz, Cornelia Betsch |
| 20 |
[GO] |
2021―May―11 |
Authors’ Reply to Sprengholz and Betsch: “Willingness to Pay for a COVID-19 Vaccine” |
Leidy Y. García, Arcadio A. Cerda |
| 21 |
[GO] |
2021―Feb―23 |
Willingness to Pay for a COVID-19 Vaccine |
Arcadio A. Cerda, Leidy Y. García |
| 22 |
[GO] |
2021―Jan―20 |
The Vatican City State Internal Healthcare System Response to COVID-19 Pandemic: Prevention and Control Strategies |
Andrea Arcangeli, Massimo Ralli, Fabio De-Giorgio, Paolo Maurizio Soave, Lucia Ercoli |
| 23 |
[GO] |
2021―Jan―13 |
How Many Intensive Care Beds are Justifiable for Hospital Pandemic Preparedness? A Cost-effectiveness Analysis for COVID-19 in Germany |
Afschin Gandjour |
| 24 |
[GO] |
2020―Aug―24 |
Comment on: “The Italian NHS: What Lessons to Draw from COVID-19?” |
Davide Golinelli, Andrea Bucci, Kadjo Yves Cedric Adja, Fabrizio Toscano |
| 25 |
[GO] |
2020―Jun―03 |
The Efficacy of Lockdown Against COVID-19: A Cross-Country Panel Analysis |
Vincenzo Alfano, Salvatore Ercolano |
| 26 |
[GO] |
2020―May―26 |
The Italian NHS: What Lessons to Draw from COVID-19? |
Livio Garattini, Michele Zanetti, Nicholas Freemantle |
| 27 |
[GO] |
2020―May―21 |
Using Insights from Behavioral Economics to Mitigate the Spread of COVID-19 |
Moslem Soofi, Farid Najafi, Behzad Karami-Matin |
| 28 |
[GO] |
2020―May―07 |
Impact of a Global Pandemic on Health Technology Assessment |
Paula K. Lorgelly, Amanda Adler |
| 29 |
[GO] |
2020―Apr―16 |
The Case for a Temporary COVID-19 Income Tax Levy Now, During the Crisis |
Jonathan Karnon |
| 30 |
[GO] |
2020―Apr―08 |
Why Only Test Symptomatic Patients? Consider Random Screening for COVID-19 |
William V. Padula |
| 31 |
[GO] |
2020―Apr―05 |
A Simple Decision Analysis of a Mandatory Lockdown Response to the COVID-19 Pandemic |
Jonathan Karnon |
| 32 |
[GO] |
2020―Apr―05 |
COVID-19 Pandemic, a War to be Won: Understanding its Economic Implications for Africa |
John E. Ataguba |
